182 related articles for article (PubMed ID: 20166943)
1. Review of 5-HT4R ligands: state of art and clinical applications.
Bureau R; Boulouard M; Dauphin F; Lezoualc'h F; Rault S
Curr Top Med Chem; 2010; 10(5):527-53. PubMed ID: 20166943
[TBL] [Abstract][Full Text] [Related]
2. Serotonin 5-HT3 and 5-HT4 ligands: an update of medicinal chemistry research in the last few years.
Modica MN; Pittalà V; Romeo G; Salerno L; Siracusa MA
Curr Med Chem; 2010; 17(4):334-62. PubMed ID: 20015043
[TBL] [Abstract][Full Text] [Related]
3. Arylpiperazine derivatives acting at 5-HT(1A) receptors.
López-Rodríguez ML; Ayala D; Benhamú B; Morcillo MJ; Viso A
Curr Med Chem; 2002 Feb; 9(4):443-69. PubMed ID: 11945120
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and pharmacological evaluation of multitarget-directed ligands with both serotonergic subtype 4 receptor (5-HT4R) partial agonist and 5-HT6R antagonist activities, as potential treatment of Alzheimer's disease.
Yahiaoui S; Hamidouche K; Ballandonne C; Davis A; de Oliveira Santos JS; Freret T; Boulouard M; Rochais C; Dallemagne P
Eur J Med Chem; 2016 Oct; 121():283-293. PubMed ID: 27266998
[TBL] [Abstract][Full Text] [Related]
5. Structure-activity relationships of serotonin 5-HT
Thirumaran SL; Lepailleur A; Rochais C
Eur J Med Chem; 2019 Dec; 183():111705. PubMed ID: 31581003
[TBL] [Abstract][Full Text] [Related]
6. Emerging opportunities and concerns for drug discovery at serotonin 5-HT2B receptors.
Brea J; Castro-Palomino J; Yeste S; Cubero E; Párraga A; Domínguez E; Loza MI
Curr Top Med Chem; 2010; 10(5):493-503. PubMed ID: 20166944
[TBL] [Abstract][Full Text] [Related]
7. Latest advances towards the discovery of 5-HT(7) receptor ligands.
Pittala V; Pittala D
Mini Rev Med Chem; 2011 Nov; 11(13):1108-21. PubMed ID: 22353220
[TBL] [Abstract][Full Text] [Related]
8. Molecular design based on 3D-pharmacophore. Application to 5-HT4 receptor.
Bureau R; Daveu C; Lemaître S; Dauphin F; Landelle H; Lancelot JC; Rault S
J Chem Inf Comput Sci; 2002; 42(4):962-7. PubMed ID: 12132898
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic modulators of the serotonin 5-HT
Lanthier C; Dallemagne P; Lecoutey C; Claeysen S; Rochais C
Expert Opin Ther Pat; 2020 Jul; 30(7):495-508. PubMed ID: 32400221
[TBL] [Abstract][Full Text] [Related]
10. [Physiopathological and therapeutic perspectives on the new serotonin receptors: the type 4 receptor].
Lefebvre H
Rev Med Interne; 2000 Aug; 21(8):661-3. PubMed ID: 10989490
[No Abstract] [Full Text] [Related]
11. Recent advances in the discovery of selective and non-selective 5-HT(1D) receptor ligands.
Ward SE; Watson JM
Curr Top Med Chem; 2010; 10(5):479-92. PubMed ID: 20166947
[TBL] [Abstract][Full Text] [Related]
12. Serotonin receptors and therapeutics.
Launay JM; Callebert J; Bondoux D; Loric S; Maroteaux L
Cell Mol Biol (Noisy-le-grand); 1994 May; 40(3):327-36. PubMed ID: 7522716
[TBL] [Abstract][Full Text] [Related]
13. Pharmacophore models for metabotropic 5-HT receptor ligands.
Bojarski AJ
Curr Top Med Chem; 2006; 6(18):2005-26. PubMed ID: 17017971
[TBL] [Abstract][Full Text] [Related]
14. 5-HT(4) receptor antagonists: structure-affinity relationships and ligand-receptor interactions.
López-Rodriguez ML; Benhamú B; Morcillo MJ; Murcia M; Viso A; Campillo M; Pardob L
Curr Top Med Chem; 2002 Jun; 2(6):625-41. PubMed ID: 12052197
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and pharmacological properties of novel hydrophilic 5-HT4 receptor antagonists.
Brudeli B; Moltzau LR; Andressen KW; Krobert KA; Klaveness J; Levy FO
Bioorg Med Chem; 2010 Dec; 18(24):8600-13. PubMed ID: 21075638
[TBL] [Abstract][Full Text] [Related]
16. 5-hydroxytryptamine (5-HT) receptor ligands.
Kitson SL
Curr Pharm Des; 2007; 13(25):2621-37. PubMed ID: 17897004
[TBL] [Abstract][Full Text] [Related]
17. Dual role of serotonin in the pathogenesis of indomethacin-induced small intestinal ulceration: pro-ulcerogenic action via 5-HT3 receptors and anti-ulcerogenic action via 5-HT4 receptors.
Kato S; Matsuda N; Matsumoto K; Wada M; Onimaru N; Yasuda M; Amagase K; Horie S; Takeuchi K
Pharmacol Res; 2012 Sep; 66(3):226-34. PubMed ID: 22699012
[TBL] [Abstract][Full Text] [Related]
18. 5-HT4 receptors.
Bockaert J; Claeysen S; Compan V; Dumuis A
Curr Drug Targets CNS Neurol Disord; 2004 Feb; 3(1):39-51. PubMed ID: 14965243
[TBL] [Abstract][Full Text] [Related]
19. Chemical update on the potential for serotonin 5-HT
Kucwaj-Brysz K; Baltrukevich H; Czarnota K; Handzlik J
Bioorg Med Chem Lett; 2021 Oct; 49():128275. PubMed ID: 34311086
[TBL] [Abstract][Full Text] [Related]
20. Investigations on the 1-(2-biphenyl)piperazine motif: identification of new potent and selective ligands for the serotonin(7) (5-HT(7)) receptor with agonist or antagonist action in vitro or ex vivo.
Lacivita E; Patarnello D; Stroth N; Caroli A; Niso M; Contino M; De Giorgio P; Di Pilato P; Colabufo NA; Berardi F; Perrone R; Svenningsson P; Hedlund PB; Leopoldo M
J Med Chem; 2012 Jul; 55(14):6375-80. PubMed ID: 22738316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
